Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arrigo Schieppati

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|September 21, 2002
Tacrolimus and ciclosporin microemulsion in renal transplantationArrigo Schieppati, Norberto Perico, Giuseppe Remuzzi
The New England Journal of Medicine|April 12, 2002
Clinical practice. Nephropathy in patients with type 2 diabetesGiuseppe Remuzzi, Arrigo Schieppati, Piero Ruggenenti
Seminars in Nephrology|August 19, 2003
Nonimmunosuppressive therapy of membranous nephropathyArrigo Schieppati, Piero Ruggenenti, Annalisa Perna, et al.
Kidney International. Supplement|July 15, 2005
The future of renoprotectionNorberto Perico, Igor Codreanu, Arrigo Schieppati, et al.
Kidney International. Supplement|March 9, 2005
The scientific care for prevention: an overviewNorberto Perico, Igor Codreanu, Arrigo Schieppati, et al.
Recenti Progressi in Medicina|May 30, 2019
[Drugs for rare diseases: the blessing of being orphans.]Enrico Costa, Arrigo Schieppati, Lucio Luzzatto, et al.
Lancet (London, England)|April 23, 2019
Orphan drugs - Authors' replyLucio Luzzatto, Enrico Costa, Arrigo Schieppati, et al.
Kidney International. Supplement|August 20, 2005
Prevention of progression and remission/regression strategies for chronic renal diseases: can we do better now than five years ago?Norberto Perico, Igor Codreanu, Arrigo Schieppati, et al.
Kidney International. Supplement|March 9, 2005
Pathophysiology of disease progression in proteinuric nephropathiesNorberto Perico, Igor Codreanu, Arrigo Schieppati, et al.
Community Genetics|October 16, 2003
Tackling the problem of rare diseases in public health: the Italian approachDomenica Taruscio, Moges Seyoum Ido, Erica Daina, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|September 21, 2002
Tacrolimus and ciclosporin microemulsion in renal transplantationArrigo Schieppati, Norberto Perico, Giuseppe Remuzzi
The New England Journal of Medicine|April 12, 2002
Clinical practice. Nephropathy in patients with type 2 diabetesGiuseppe Remuzzi, Arrigo Schieppati, Piero Ruggenenti
Seminars in Nephrology|August 19, 2003
Nonimmunosuppressive therapy of membranous nephropathyArrigo Schieppati, Piero Ruggenenti, Annalisa Perna, et al.
Kidney International. Supplement|July 15, 2005
The future of renoprotectionNorberto Perico, Igor Codreanu, Arrigo Schieppati, et al.
Kidney International. Supplement|March 9, 2005
The scientific care for prevention: an overviewNorberto Perico, Igor Codreanu, Arrigo Schieppati, et al.
Recenti Progressi in Medicina|May 30, 2019
[Drugs for rare diseases: the blessing of being orphans.]Enrico Costa, Arrigo Schieppati, Lucio Luzzatto, et al.
Lancet (London, England)|April 23, 2019
Orphan drugs - Authors' replyLucio Luzzatto, Enrico Costa, Arrigo Schieppati, et al.
Kidney International. Supplement|August 20, 2005
Prevention of progression and remission/regression strategies for chronic renal diseases: can we do better now than five years ago?Norberto Perico, Igor Codreanu, Arrigo Schieppati, et al.
Kidney International. Supplement|March 9, 2005
Pathophysiology of disease progression in proteinuric nephropathiesNorberto Perico, Igor Codreanu, Arrigo Schieppati, et al.
Community Genetics|October 16, 2003
Tackling the problem of rare diseases in public health: the Italian approachDomenica Taruscio, Moges Seyoum Ido, Erica Daina, et al.
Pageof 6